BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31925646)

  • 1. Modulation of aryl hydrocarbon receptor inhibits esophageal squamous cell carcinoma progression by repressing COX2/PGE2/STAT3 axis.
    Zhu P; Zhou K; Lu S; Bai Y; Qi R; Zhang S
    J Cell Commun Signal; 2020 Jun; 14(2):175-192. PubMed ID: 31925646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
    Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
    J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the acid suppressor omeprazole on the proliferation, migration, invasion and cell cycle of esophageal squamous cell carcinoma cells via the aryl hydrocarbon receptor pathway.
    Bai Y; Zhu P; Zhou K; Zhang SG
    Exp Ther Med; 2021 Oct; 22(4):1187. PubMed ID: 34475977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR/CYP1A1 signalling.
    Yin H; Zhang J; Zhang H; Li Q; Qiu H; Hong K; Wang W; Xiao Y; Yu B
    FEBS J; 2023 Feb; 290(3):837-854. PubMed ID: 36070107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis.
    Li Z; Qin X; Bian W; Li Y; Shan B; Yao Z; Li S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):477. PubMed ID: 31775815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2.
    Xuan X; Li S; Lou X; Zheng X; Li Y; Wang F; Gao Y; Zhang H; He H; Zeng Q
    Mol Biol Rep; 2015 May; 42(5):907-15. PubMed ID: 25407307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Tan D; Wu Y; Hu L; He P; Xiong G; Bai Y; Yang K
    Dis Esophagus; 2017 Jan; 30(1):1-9. PubMed ID: 27247022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of long noncoding RNA breast cancer anti-estrogen resistance 4 inhibits cell proliferation, invasion, and migration in esophageal squamous cell carcinoma by regulating the microRNA-181c-5p/LIM and SH3 protein 1 axis.
    Ke S; Fang M; Li R; Wang J; Lu J
    Bioengineered; 2022 May; 13(5):12998-13010. PubMed ID: 35611706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.
    Zeng YZ; Zhang YQ; Chen JY; Zhang LY; Gao WL; Lin XQ; Huang SM; Zhang F; Wei XL
    Front Oncol; 2021; 11():627713. PubMed ID: 33854967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of aryl hydrocarbon receptor suppresses invasion of esophageal squamous cell carcinoma cell lines.
    Zhang J; Zong H; Li S; Zhang D; Zhang L; Xia Q
    Tumori; 2012; 98(1):152-7. PubMed ID: 22495716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK11
    Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
    Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated STAT3 Could Reduce Survival in Patients with Esophageal Squamous Cell Carcinoma by Up-regulating VEGF and Cyclin D1 Expression.
    Zhang N; Zhang M; Wang Z; Gao W; Sun ZG
    J Cancer; 2020; 11(7):1859-1868. PubMed ID: 32194797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
    Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5391-5403. PubMed ID: 32495874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
    Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
    World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of cervical carcinoma expressed PCNA regulatory long non-coding RNA promotes esophageal squamous cell carcinoma progression.
    Wang X; Zhou L; Zhang H; Ou H; Long W; Liu X
    Oncol Lett; 2020 Nov; 20(5):142. PubMed ID: 32934710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.